Biontech: Biotechnology company from Germany
BioNTech SE (ˈbaɪɒnˌtek) is a German biotechnology company dedicated to the creation of active immunotherapies for treatments of serious diseases.
Wiki Simple English | |
| Company type | Public (SE) |
|---|---|
| NASDAQ: BNTX | |
| ISIN | US09075V1026 |
| Industry | Biotechnology |
| Founded | 2008 |
| Founders |
|
| Headquarters | , Germany |
Number of locations | 8 (2022) |
Area served | Worldwide |
Key people |
|
| Products | BNT162b2 |
| Services | Immunotherapy |
| Revenue |  €17.3 billion (2022) |
| €12.6 billion (2022) | |
| €9.43 billion (2022) | |
| Total assets |  €23.3 billion (2022) |
| Total equity | €20.1 billion (2022) |
Number of employees | 4,530 (2022) |
| Website | biontech |
| Footnotes / references Biontech FY 2022 report | |
It researches drugs based on messenger RNA (mRNA) for use as individualized cancer immunotherapies, as vaccines against infectious diseases and as protein replacement therapies for rare diseases. In 2020, the company started developing the BNT162b2 vaccine against SARS-CoV-2 with Pfizer and Fosun. In late 2020 BioNTech successfully developed, together with Pfizer, the RNA vaccine called BNT162b2 against COVID-19. The company said, it's vaccine efficacy was 95%. On 2 December 2020, the United Kingdom government gave permission to use BNT162b2 vaccinations in the country. Later in December 2020 USA, Canada and the EU also gave permission to use the BioNTech vaccine.
References
This article uses material from the Wikipedia Simple English article BioNTech, which is released under the Creative Commons Attribution-ShareAlike 3.0 license ("CC BY-SA 3.0"); additional terms may apply (view authors). Content is available under CC BY-SA 4.0 unless otherwise noted. Images, videos and audio are available under their respective licenses.
®Wikipedia is a registered trademark of the Wiki Foundation, Inc. Wiki Simple English (DUHOCTRUNGQUOC.VN) is an independent company and has no affiliation with Wiki Foundation.